1. A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses. Issue 38 (7th September 2021) Authors: Eldridge, John H.; Egan, Michael A.; Matassov, Demetrius; Hamm, Stefan; Hermida, Luz; Chen, Tracy; Tremblay, Marc; Sciotto-Brown, Susan; Xu, Rong; Dimitrov, Antony; Smith, Emily R.; Gurwith, Marc; Chen, Robert T. Journal: Vaccine Issue: Volume 39:Issue 38(2021) Page Start: 5436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates. (25th June 2018) Authors: Woolsey, Courtney; Geisbert, Joan B; Matassov, Demetrius; Agans, Krystle N; Borisevich, Viktoriya; Cross, Robert W; Deer, Daniel J; Fenton, Karla A; Eldridge, John H; Mire, Chad E; Geisbert, Thomas W Journal: Journal of infectious diseases Issue: Volume 218(2018)Supplement 5 Page Start: S582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial. Issue 4 (April 2020) Authors: Clarke, David K; Xu, Rong; Matassov, Demetrius; Latham, Theresa E; Ota-Setlik, Ayuko; Gerardi, Cheryl S; Luckay, Amara; Witko, Susan E; Hermida, Luz; Higgins, Terry; Tremblay, Marc; Sciotto-Brown, Susan; Chen, Tracy; Egan, Michael A; Rusnak, Janice M; Ward, Lucy A; Eldridge, John H Journal: Lancet infectious diseases Issue: Volume 20:Issue 4(2020) Page Start: 455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗